The Burden of Illness of Employees on United States Employers: A Critical Review of the Literature

被引:0
作者
Devidas Menon
Lila Assiff
机构
[1] Institute of Health Economics,Department of Public Health Sciences, Faculty of Medicine and Dentistry
[2] University of Alberta,undefined
来源
Drug information journal : DIJ / Drug Information Association | 2000年 / 34卷
关键词
Sick leave; Absenteeism; Cost of illness; Employer health costs; United States;
D O I
暂无
中图分类号
学科分类号
摘要
Diseases such as Alzheimer’s disease, asthma, cardiovascular disease, depression, gastrointestinal disease, HIV/AIDS, infectious disease, and migraine cast a significant burden of employees on United States employers. The purpose of this study was to critically review published literature on the burden of diseases. The results indicate that there are very few studies published with data on the burden of illness on United States employers. Only 35 articles were found discussing indirect costs of illness such as absenteeism, productivity, short- or long-term disability (STD, LTD) and drug costs. Interpretation of these cost analyses is limited because of variation in methodology and measures between the studies. These include monetary and nonmonetary measures, obtained from different groups of patients using different techniques. Although the results confirm that these diseases have a significant impact on employers, there is no standardized measure to quantitate this impact. The current state of the literature suggests that primary research studies should be conducted with large firms or organizations to determine the actual impact of employee illness.
引用
收藏
页码:47 / 58
页数:11
相关论文
共 87 条
  • [1] Conti DJ(1994)The economic impact of depression in a workplace J Occupation Med. 36 983-988
  • [2] Burton WN(1994)Costs to business for an HIV-infected worker Inquiry. 31 76-88
  • [3] Farnham PG(1995)Potential and actual workdays lost among patients with HIV J Acquired Immune Deficiency Syndromes Human Retrovirology. 8 392-398
  • [4] Gorsky RD(1997)Cost benefit of sumatriptan to an employer J Occupation Environment Med. 39 652-657
  • [5] Leigh JP(1992)An economic evaluation of asthma in the United States New Engl J Med. 326 862-866
  • [6] Lubeck DP(1994)The impact of pharmacologic therapy on the costs of asthma Allergy Proceed. 15 189-192
  • [7] Famham P(1997)A national estimate of the economic costs of asthma Am J Respiratory Critical Care Med. 156 787-793
  • [8] Legg RF(1995)A self-management program for adult asthma. Part II: Cost-benefit analysis J Allergy Clin Immunol. 95 672-676
  • [9] Sclar DA(1993)Work disability among adults with asthma Chest Vol. 104 1371-1377
  • [10] Nemec NL(1996)The economic costs of cardiovascular disease mortality in California, 1991: implications for public health policy J Public Health Policy. 17 442-459